ELRIG
Since incorporation in 2004, ELRIG has consolidated its reputation as a best in industry UK-based not-for-profit volunteer-led organisation, operated by and for the drug discovery community, and dedicated to the delivery of leading-edge scientific meetings and conferences on an open-access basis for optimum accessibility across all levels of its 22,000-strong global community.The Board delegates its tasks to a series of Work Groups, who work with the ELRIG team to ensure it achieves its objectives.ELRIG continuously strives to advance its ED&I and sustainability strategic pillars, to both inspire and align with the ESG strategies of its delegates, exhibitors, sponsors and all other stakeholders.For more information, visit the ELRIG website or follow on LinkedIn, X (formerly Twitter), Instagram and Bluesky.Content by ELRIG
| 5 min read
Three keynotes at GSK Stevenage in November make the case that AI has sharpened, not settled, the hardest problems in protein sciences drug discovery
| 2 min read
Backed by Pfizer and DDN, ELRIG’s first US conference aims to strengthen transatlantic collaboration in drug discovery and spotlight innovative strategies for modulating previously intractable targets.
Page 1 of 1 - 2 Total Items
